• Company
• Therapeutic device 'improves OS for lung cancer patients'
• by Son, Hyung Min Oct 21, 2024 05:48am

• Company
• Oxlumo receives orphan drug designation in Korea
• by Eo, Yun-Ho Oct 21, 2024 05:48am

• Company
• RNAi therapeutic 'Givlaari' receives the ODD in KOR
• by Eo, Yun-Ho Oct 21, 2024 05:48am

• Policy
• How to stabilize supply of national essential medicines
• by Lee, Hye-Kyung Oct 18, 2024 05:49am

• Policy
• 'Can the Yoon administration develop blockbuster drugs?'
• by Lee, Jeong-Hwan Oct 18, 2024 05:49am

• Company
• Bladder cancer drug Balversa offers new treatment option
• by Whang, byung-woo Oct 18, 2024 05:49am

• Company
• 'Vorasidenib' receives Orphan Drug Designation in KOR
• by Eo, Yun-Ho Oct 18, 2024 05:49am

• Company
• Will blockbuster contraception Mercilon find a new provider?
• by Nho, Byung Chul Oct 18, 2024 05:49am

• Policy
• Gov't opposes to suspending reimb·ingredient prescribing
• by Lee, Jeong-Hwan Oct 17, 2024 05:52am

• Policy
• HIRA President, "Copayment ratio needs to be adjusted
• by Lee, Tak-Sun Oct 17, 2024 05:51am